Literature DB >> 20192993

Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice.

Veena Taneja1, Chella S David.   

Abstract

Predisposition to develop rheumatoid arthritis (RA) has been associated with certain human leukocyte antigen (HLA) class II molecules, although the mechanism is still unknown. Various experimental animal models of inflammatory arthritis have been studied to address the role of major histocompatibility complex (MHC) genes in pathogenesis. We have generated transgenic mice expressing HLA class II molecules (DR and DQ) lacking complete endogenous class II molecules to study the interactions involved between class II molecules (DQ and DR) and to define the immunologic mechanisms in inflammatory arthritis. The HLA transgene can positively select CD4(+) T cells expressing various V beta T-cell receptors, and a peripheral tolerance is maintained to transgenic HLA molecules. The expression of HLA molecules on various cells in these mice is similar to that known in humans. In this review, we describe collagen-induced arthritis as a model for human inflammatory arthritis using these transgenic mice. The transgenic mice carrying RA-susceptible haplotype develop gender-biased inflammatory arthritis with clinical and histopathological similarities to RA. Our studies show that polymorphism of HLA class II genes determine the predisposition to rheumatoid/inflammatory arthritis and the epistatic interactions between HLA-DQ and HLA-DR molecules dictate the severity, progression, and modulation of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192993     DOI: 10.1111/j.0105-2896.2009.00858.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  31 in total

1.  [How do T-cells become activated in joints?].

Authors:  M Pierer; U Wagner
Journal:  Z Rheumatol       Date:  2010-10       Impact factor: 1.372

2.  Immune response to immunodominant Mycobacterium tuberculosis antigen ESAT-6 derived peptide is HLA-haplotype dependent.

Authors:  Michele Smart; Marshall Behrens; Luckey David; Catherine Conway; Veena Taneja
Journal:  Jacobs J Allergy Immunol       Date:  2014-09-05

3.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

4.  A model for personalized in vivo analysis of human immune responsiveness.

Authors:  Hannes Kalscheuer; Nichole Danzl; Takashi Onoe; Ted Faust; Robert Winchester; Robin Goland; Ellen Greenberg; Thomas R Spitzer; David G Savage; Hiroyuki Tahara; Goda Choi; Yong-Guang Yang; Megan Sykes
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

Review 5.  B cells as effectors and regulators of sex-biased arthritis.

Authors:  David Luckey; Kay Medina; Veena Taneja
Journal:  Autoimmunity       Date:  2012-08       Impact factor: 2.815

Review 6.  To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.

Authors:  Marshall Behrens; Michele Smart; David Luckey; Harvinder Luthra; Veena Taneja
Journal:  J Autoimmun       Date:  2011-06-12       Impact factor: 7.094

7.  Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma.

Authors:  S Ma; J Wu; J Wu; Y Wei; L Zhang; Q Ning; D Hu
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 8.  Immunogenetic control of the intestinal microbiota.

Authors:  Eric Marietta; Abdul Rishi; Veena Taneja
Journal:  Immunology       Date:  2015-06-03       Impact factor: 7.397

9.  Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.

Authors:  Rushikesh Sable; Thomas Durek; Veena Taneja; David J Craik; Sandeep Pallerla; Ted Gauthier; Seetharama Jois
Journal:  ACS Chem Biol       Date:  2016-07-01       Impact factor: 5.100

10.  CD74/DQA1 dimers predispose to the development of arthritis in humanized mice.

Authors:  Luckey David; Ameya Gokhale; Seetharama Jois; Aaron Johnson; Marshall Behrens; Harvinder Luthra; Veena Taneja
Journal:  Immunology       Date:  2015-12-21       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.